Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology

Papers
(The TQCC of Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
ArticleCitations
Recent advances in development of dendritic polymer‐based nanomedicines for cancer diagnosis145
Multifunctional MnO2 nanoparticles for tumor microenvironment modulation and cancer therapy108
Brain penetrating peptides and peptide–drug conjugates to overcome the blood–brain barrier and target CNS diseases94
Nanobody—A versatile tool for cancer diagnosis and therapeutics74
Strategies for sustained drug release from electrospun multi‐layer nanostructures72
Ultrasmall superparamagnetic iron oxide nanoparticles: A next generation contrast agent for magnetic resonance imaging64
Intrinsic stimuli‐responsive nanocarriers for smart drug delivery of antibacterial agents—An in‐depth review of the last two decades58
Isolation and characterization of extracellular vesicles and future directions in diagnosis and therapy50
Silver nanoparticles as a potential treatment against SARS‐CoV‐2: A review48
Nanocarrier‐hydrogel composite delivery systems for precision drug release47
Surface modification of nano‐drug delivery systems for enhancing antibiotic delivery and activity45
Influence of surface chemistry and morphology of nanoparticles on protein corona formation45
Mechanisms of nanoparticle radiosensitization45
Reduction‐responsive polymers for drug delivery in cancer therapy—Is there anything new to discover?44
Recent advances in applications of nanoparticles in SERS in vivo imaging42
Gold nanoparticles in virus detection: Recent advances and potential considerations for SARS‐CoV‐2 testing development40
Rational design of nanomedicine for photothermal‐chemodynamic bimodal cancer therapy40
Electrospun fibers as carriers for topical drug delivery and release in skin bandages and patches for atopic dermatitis treatment40
Clinical magnetic hyperthermia requires integrated magnetic particle imaging37
Nucleic acid‐based electrochemical biosensor: Recent advances in probe immobilization and signal amplification strategies35
Synthetic cells in biomedical applications35
Stimuli‐responsive nanoplatforms for antibacterial applications35
Catalytic antimicrobial therapy using nanozymes32
Copper‐based nanomaterials for cancer theranostics32
Advances of nanomaterial applications in oral and maxillofacial tissue regeneration and disease treatment31
Advancements in release‐active antimicrobial biomaterials: A journey from release to relief31
Advancements in protein nanoparticle vaccine platforms to combat infectious disease31
Recent developments in the use of gold and silver nanoparticles in biomedicine29
Opportunities and challenges for the clinical translation of structured DNA assemblies as gene therapeutic delivery and vaccine vectors29
Recent advances in combination of microneedles and nanomedicines for lymphatic targeted drug delivery28
Nanobiotechnology‐enabled energy utilization elevation for augmenting minimally‐invasive and noninvasive oncology thermal ablation27
Two‐dimensional metal organic frameworks for biomedical applications27
Applications of nanotechnology in virus detection, tracking, and infection mechanisms26
Chiral fiber supramolecular hydrogels for tissue engineering26
Red blood cells membrane‐derived nanoparticles: Applications and key challenges in their clinical translation25
Advances in cell penetrating peptides and their functionalization of polymeric nanoplatforms for drug delivery25
Biohybrid robotics: From the nanoscale to the macroscale24
Engineering gold nanoparticles for molecular diagnostics and biosensing24
Titanium dioxide nanoparticles: Recent progress in antimicrobial applications24
Cell membrane‐coated nanoparticles for the treatment of bacterial infection23
Exploring the applications of hyaluronic acid‐based nanoparticles for diagnosis and treatment of bacterial infections23
Nanotechnology meets glioblastoma multiforme: Emerging therapeutic strategies22
Optimal delivery of poorly soluble drugs using electrospun nanofiber technology: Challenges, state of the art, and future directions22
Cancer‐associated‐platelet‐inspired nanomedicines for cancer therapy21
Combinational application of metal–organic frameworks‐based nanozyme and nucleic acid delivery in cancer therapy21
Nanomedicine in lung cancer: Current states of overcoming drug resistance and improving cancer immunotherapy21
Recent progress in layered double hydroxides as a cancer theranostic nanoplatform21
Advances in single‐molecule fluorescent nanosensors21
Challenges in the development of nanoparticle‐based imaging agents: Characterization and biology21
In vitro dissolution considerations associated with nano drug delivery systems20
Dark‐field hyperspectral imaging for label free detection of nano‐bio‐materials20
Cell mimicry as a bottom‐up strategy for hierarchical engineering ofnature‐inspiredentities20
Remodeling tumor microenvironment with nanomedicines19
Hot melt extrusion: An emerging manufacturing method for slow and sustained protein delivery19
Recent advances on transdermal delivery systems for the treatment of arthritic injuries: From classical treatment to nanomedicines19
Nanomedicines for combating multidrug resistance of cancer19
Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy18
Therapeutic gas delivery strategies18
Crosslinked polymer nanocapsules for therapeutic, diagnostic, and theranostic applications18
Toward nanobioelectronic medicine: Unlocking new applications using nanotechnology18
Management of osteoarthritis: From drug molecules to nano/micromedicines18
Targeting cancer metastasis with antibody therapeutics17
From infection to healing: The use of plant viruses in bioactive hydrogels17
Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma17
Nanoparticle mediated RNA delivery for wound healing17
Direct nose to the brain nanomedicine delivery presents a formidable challenge17
Brain‐targeting drug delivery systems16
Engineering spatiotemporal organization and dynamics in synthetic cells16
A review on RNAi therapy for NSCLC: Opportunities and challenges16
Radiolabeling strategies and pharmacokinetic studies for metal based nanotheranostics16
Inflammation‐modulating nanoparticles for pneumonia therapy16
Magnetic particle imaging for assessment of cerebral perfusion and ischemia15
Graphene nanocomposites for transdermal biosensing15
J‐aggregation strategy of organic dyes for near‐infrared bioimaging and fluorescent image‐guided phototherapy15
Aptamer‐functionalized hydrogels: An emerging class of biomaterials for protein delivery, cell capture, regenerative medicine, and molecular biosensing15
Functionalizing DNA nanostructures for therapeutic applications14
Stimuli‐responsive polypeptide nanoassemblies: Recent progress and applications in cancer nanomedicine14
Nano‐diagnostics as an emerging platform for oral cancer detection: Current and emerging trends14
Nanoparticle platforms for dermal antiaging technologies: Insights in cellular and molecular mechanisms14
Biomaterials and nanomaterials for sustained release vaccine delivery14
Nanotechnology‐based approaches for treating lysosomal storage disorders, a focus on Fabry disease14
Dendrimers for cancer immunotherapy: Avidity‐based drug delivery vehicles for effective anti‐tumor immune response14
Recent approaches in nanocarrier‐based therapies for neglected tropical diseases14
Toxicokinetics, dose–response, and risk assessment of nanomaterials: Methodology, challenges, and future perspectives14
Ultrasound‐mediated nano‐sized drug delivery systems for cancer treatment: Multi‐scale and multi‐physics computational modeling13
Theragnostic nanomotors: Successes and upcoming challenges13
Endotoxin contamination of engineered nanomaterials: Overcoming the hurdles associated with endotoxin testing13
Current development of cabazitaxel drug delivery systems13
0.047679901123047